venBio Partners LLC
- SEC CIK
- 0001776382
- Latest filing
- Aug 14, 2026
Holdings in Q2 2023
Holdings as of Jun 30, 2023, filed Aug 14, 2023. Long positions only; changes compare share counts with Q1 2023.
- Positions
- 7
- +1 vs. Q1 2023
- Portfolio value
- $276.3M
- +$95.9M (+53.1%) vs. Q1 2023
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| SLRNACELYRIN, Inc. | COM | 3,857,230 | $80.6M | 29.2% | +3,857,230 | New | History |
| ALXOAlx Oncology Holdings Inc | COM | 9,699,925 | $72.8M | 26.4% | 00.0% | Unchanged | History |
| PHVSPharvaris N.V. | COM | 4,264,672 | $64.6M | 23.4% | +1,986,097+87.2% | Added | History |
| HRMYHarmony Biosciences Holdings, Inc. | COM | 1,035,396 | $36.4M | 13.2% | 00.0% | Unchanged | History |
| VTYXVentyx Biosciences, Inc. | COM | 424,032 | $13.9M | 5.0% | −1,874,801−81.6% | Reduced | History |
| ELEVElevation Acquisition Group Inc. | COM | 2,914,255 | $4.43M | 1.6% | +1,047,916+56.1% | Added | History |
| IMPLIPI Legacy Liquidation Co | COM | 2,759,791 | $3.50M | 1.3% | 00.0% | Unchanged | History |